Proteome Sciences (LON:PRM) Reaches New 12-Month Low – Time to Sell?

Proteome Sciences plc (LON:PRMGet Free Report) shares reached a new 52-week low during trading on Friday . The stock traded as low as GBX 2.50 ($0.03) and last traded at GBX 3.10 ($0.04), with a volume of 35320 shares traded. The stock had previously closed at GBX 2.88 ($0.04).

Proteome Sciences Stock Up 7.6 %

The company has a market cap of £9.15 million, a price-to-earnings ratio of -310.00 and a beta of 0.07. The firm has a 50-day simple moving average of GBX 3.17 and a 200 day simple moving average of GBX 3.44.

About Proteome Sciences

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Read More

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.